Drug Shortage Report for ACT RISPERIDONE
Report ID | 3337 |
Drug Identification Number | 02282623 |
Brand name | ACT RISPERIDONE |
Common or Proper name | RISPERIDONE |
Company Name | ACTAVIS PHARMA COMPANY |
Market Status | MARKETED |
Active Ingredient(s) | RISPERIDONE |
Strength(s) | 3MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 60 |
ATC code | N05AX |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-03-17 |
Estimated end date | 2017-06-07 |
Actual end date | 2017-08-01 |
Shortage status | Resolved |
Updated date | 2017-09-19 |
Company comments | |
Health Canada comments | |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.